SCHEMBL2428833

SCHEMBL2428833

C=CC(=O)OCc1ccc(OC)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.50
THRB P10828 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
ALOX12 P18054 1/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 1/20 0.49
POLB P06746 1/20 0.49
RAB9A P51151 1/20 0.49
FFAR1 O14842 2/20 0.48
MIF P14174 1/20 0.48
MMP9 P14780 2/20 0.48
MMP1 P03956 1/20 0.48
TGM2 P21980 1/20 0.47
IDO1 P14902 2/20 0.47
AGXT P21549 2/20 0.47
MMP2 P08253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14087657 0.95 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2THRBTP53CYP3A4
SCHEMBL2556244 0.87 HCAR2 (0.50) ALDH1A1SMN1; SMN2THRBTP53CYP3A4
SCHEMBL28441946 0.86 TSHR (0.51) ALDH1A1SMN1; SMN2THRBTP53CYP3A4
SCHEMBL8805993 0.86 HCAR2 (0.56) ALDH1A1SMN1; SMN2HTTNPC1POLB
SCHEMBL10882382 0.86 THRB (0.49) ALDH1A1SMN1; SMN2THRBTP53CYP3A4
SCHEMBL12284434 0.86 THRB (0.62) ALDH1A1THRBTP53CYP3A4TSHR
SCHEMBL10399767 0.86 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2HTTNPC1POLB
SCHEMBL11202085 0.86 HCAR2 (0.56) ALDH1A1SMN1; SMN2HTTNPC1POLB
SCHEMBL22621370 0.84 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2THRBTP53CYP3A4
SCHEMBL8016679 0.84 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2HTTNPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE SLINGSHOT BIOSCIENCES, INC. (US) 2025-12-25 US claimed
US-20250298042-A1 ENGINEERED PARTICLES AS RED BLOOD CELL MIMICS AND COMPOSITIONS CONTAINING SAME FOR HEMATOLOGY SLINGSHOT BIOSCIENCES, INC. (US) 2025-09-25 US claimed
EP-4608872-A2 SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION Slingshot Biosciences, Inc. (US) 2025-09-03 EP claimed
US-12379387-B2 Engineered particles as red blood cell mimics and compositions containing same for hematology SLINGSHOT BIOSCIENCES, INC. (US) 2025-08-05 US claimed
EP-3256850-B1 HYDROGEL PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME SLINGSHOT BIOSCIENCES INC (US) 2025-07-09 EP claimed
US-12352679-B2 Synthetic human cell mimic particle for cytometric or coulter device SLINGSHOT BIOSCIENCES, INC. (US) 2025-07-08 US claimed
US-12312595-B2 Hydrogel particles as feeder cells and as synthetic antigen presenting cells SLINGSHOT BIOSCIENCES, INC. (US) 2025-05-27 US claimed
US-20250164373-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE SLINGSHOT BIOSCIENCES, INC. (US) 2025-05-22 US claimed
CN-119907921-A Engineered particles as red blood cell mimics for hematology and compositions containing the same 弹弓生物科学公司 2025-04-29 CN claimed
CN-119744345-A Compositions and methods for single well multiple calibration and compensation 弹弓生物科学公司 2025-04-01 CN claimed
US-6657030-B2 High refractive index and hydrophilic monomers, a crosslinker, an initiator and water BAUSCH & LOMB INCORPORATED 2003-12-02 US claimed
US-6657029-B2 High refractive index monomer, greater amount of a hydrophilic monomer, crosslinker, and initiator; give water content; intraocular lenses BAUSCH & LOMB INCORPORATED 2003-12-02 US claimed
US-20020049290-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-04-25 US claimed
US-20020042483-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-04-11 US claimed
US-20020042484-A1 High refractive index hydrogel compositions for ophthalmic implants BAUSCH & LOMB MEXICO, S.A. DE C.V. (MX) 2002-04-11 US claimed
US-20020037984-A1 High refractive index hydrogel compositions for ophthalmic implants VANDERBILT DAVID P (US) 2002-03-28 US claimed
US-6329485-B1 FOR INTRAOCULAR LENSES BAUSCH & LOMB INCORPORATED 2001-12-11 US claimed
WO-2000034804-A1 HIGH REFRACTIVE INDEX HYDROGEL COMPOSITIONS FOR OPHTHALMIC IMPLANTS BAUSCH & LOMB SURGICAL, INC. (US) 2000-06-15 WO claimed
EP-0204444-B1 BINDER FOR ANTI-FOULING PAINTS COURTAULDS COATINGS (HOLDINGS) LIMITED (GB) 1989-08-02 EP claimed
EP-0204444-A1 Binder for anti-fouling paints COURTAULDS COATINGS (HOLDINGS) LIMITED (GB) 1986-12-10 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250389633-A1 SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICE CD4, ICOS, CD69 ALDH1A1 3752/4885SMN1; SMN2 4510/4885THRB 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.